| Business Summary | | Microcide
Pharmaceuticals
Inc.
is
a
biopharmaceutical
company
committed
to
the
discovery,
development
and
commercialization
of
novel
antimicrobials
for
the
improved
treatment
of
serious
bacterial,
fungal
and
viral
infections.
The
Company's
three
discovery
research
platforms
address
the
growing
problems
of
antibiotic
resistance,
and
the
need
for
improved
antifungal
and
antiviral
therapeutics.
The
Company's
Cephalosporin
Antibiotics
and
Efflux
Pump
Inhibition
platforms
focus
on
developing
novel
antibiotics
and
antibiotic
potentiators
(efflux
inhibitors)
to
directly
address
existing
bacterial
and
fungal
resistance
problems.
Microcide's
Microbial
Genomics
platform
utilizes
proprietary
bacterial,
fungal
and
viral
genetics
and
genomics
tools
to
discover
entirely
new
classes
of
antimicrobial
agents. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | MCDE
is
a
biopharmaceutical
co.
founded
to
discover,
develop
and
commercialize
novel
antibiotics
for
the
treatment
of
serious
bacterial
infections.
For
the
three
months
ended
3/31/01,
revenues
totaled
$2.7
million,
up
from
$1.2
million.
Net
loss
before
accounting
change
decreased
32%
to
$2.4
million.
Revenues
reflect
an
increase
in
license
fees.
Net
loss
was
partially
offset
by
increased
S/G/A
expenses
due
to
higher
personnel
related
costs. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
1,853;
after
tax
earnings
were
-3,727. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| John Walker, 52 Chairman | -- | George Miller, Ph.D., 62 Sr.
VP- R&D | $272K | Donald Huffman, 54 VP
of Fin. and Devel., CFO | 160K | Jerry Buysse, Ph.D. VP,
Discovery Biology, Assay Devel. and Screening | -- | Michael Dudley VP,
Pharmacology and Microbiology | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|